Drugs to address metabolic health issues have gained mainstream awareness, but for individuals with underactive thyroid, one class of drug has been trusted for some time. This week one of those has ...
The U.S. Food and Drug Administration (FDA) has upgraded a recall of a commonly prescribed thyroid medication due to what it described as "subpotent" active ingredients. The recall of more than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results